Project Grant HT94252410897
Award Date
11/1/24
Completion Date
10/31/27
Dollars Obligated
$698K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10065, USA
Similar Awards
This $664,456 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Sloan-Kettering Institute for Cancer Research. The award will fund a 3-year research project focused on investigating biomarkers of immune response in mismatch repair-deficient (MMR-D) endometrial cancer treated with immune checkpoint blockade and radiation. The research aims to advance the understanding of cancer immunology and develop new...
The Defense Health Agency awarded a $619,500 Project Grant to the Sloan-Kettering Institute for Cancer Research, a non-profit organization in New York, NY. The grant is funded through the Military Medical Research and Development (CFDA 12.420) program and will support research to investigate the immunogenicity and targeting of shared neoantigens in adenoid cystic cancer over a 3-year period from September 1, 2023 to August 31, 2026. The research aims to transform health care for Service...
This federal Project Grant award of $2,808,108.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research conducted by the Sloan-Kettering Institute for Cancer Research to investigate the role of clonal hematopoiesis in therapeutic resistance and metastatic relapse in breast cancer. The award period extends from March 1, 2024 to February 29, 2028. Through this funding, the Sloan-Kettering Institute will explore the...
This federal Project Grant award of $708,000.00 provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by the Sloan-Kettering Institute for Cancer Research, a non-profit organization located in New York, NY. The research project is focused on investigating the "Prevalence and Biologic Impact of FGFR3 Genomic Alterations in Bladder Cancer". The 2-year award period runs from September 15, 2023 to...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,556,809.00 to the University of Washington to develop a vaccine to prevent colorectal cancer. The award, which began on June 15, 2024 and is scheduled for completion by June 14, 2027, supports innovative biomedical research aimed at improving health outcomes for military service members, veterans, and the broader public. As a sub-award under this...
The Defense Health Agency awarded a $923,805 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Sloan-Kettering Institute for Cancer Research in New York. The grant supports a 3-year research project titled "Systematic Functional Dissection of Cancer Cell States in Lung Tumors" starting September 1, 2025. The grant aims to conduct advanced biomedical research to transform healthcare for military service members, veterans, and the broader...
The Defense Health Agency awarded a $533,308 project grant to the Sloan-Kettering Institute for Cancer Research in New York, NY under the Military Medical Research and Development (CFDA 12.420) program. The grant, which runs from September 1, 2025 to August 31, 2029, will support integrated immunomodulatory analysis of LAG3 inhibition in renal cell carcinoma. The Sloan-Kettering Institute, a leading nonprofit cancer research institution, will conduct advanced biomedical research aimed at...
The Department of Defense's Defense Health Agency awarded a $2,212,500 Project Grant to the Sloan-Kettering Institute for Cancer Research (MSKCC) under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 1, 2023, supports a 4-year research project to define the genetic determinants of head and neck cancer progression and immune evasion through computational and functional investigation. The research aims to advance scientific understanding and...
The project grant award of $880,000 is funded by the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant is awarded to the Sloan-Kettering Institute for Cancer Research to conduct research on using interferon E as a tumor suppressor and potential therapeutic for pancreatic cancer. The project will take place over a 3-year period from September 1, 2024 to August 31, 2027. As a leading comprehensive cancer...
The Defense Health Agency awarded a $1,108,654 Project Grant to the Sloan-Kettering Institute for Cancer Research under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on September 30, 2025, will fund research to accelerate global research for relapsed or refractory extracranial malignant germ cell tumors. The Sloan-Kettering Institute, a leading nonprofit cancer research institution, will leverage its extensive capabilities in cancer biology, genomics,...